Related Experiment Video
Updated: Feb 21, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Predictors of Crohn's disease
Laurent Beaugerie1, Philippe Seksik, Isabelle Nion-Larmurier
1Department of Gastroenterology, Saint-Antoine Hospital, and Pierre et Marie Curie University, Paris, France. laurent.beaugerie@sat.aphp.fr
Identifying early indicators of disabling Crohn's disease is crucial. Factors like younger age, perianal disease, and initial steroid use at diagnosis predict a severe 5-year disease course.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Epidemiology
Background:
- Crohn's disease management may involve early intensive therapy for disabling cases.
- Predicting disease severity at diagnosis is essential for treatment decisions.
Purpose of the Study:
- To identify factors at diagnosis that predict a disabling course of Crohn's disease within the first five years.
- To inform clinical decisions regarding early intensive therapy.
Main Methods:
- Retrospective analysis of 1188 Crohn's disease patients diagnosed between 1985-1998.
- Disabling disease defined by predefined clinical severity criteria within 5 years of diagnosis.
- Logistic regression used to identify independent predictive factors.
Main Results:
- 85.2% of patients experienced a disabling disease course within 5 years.
- Predictive factors at diagnosis included age < 40 (OR 2.1), perianal disease (OR 1.8), and initial steroid requirement (OR 3.1).
- High positive predictive values (0.91-0.93) observed for combinations of these factors.
Conclusions:
- Age under 40, perianal disease, and initial steroid need are key predictors of a disabling Crohn's disease course.
- These factors can help identify patients likely to benefit from early intensive treatment.
- Findings validated prospectively in an independent patient cohort.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

